BUSPIRONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Buspirone, and what generic alternatives are available?
Buspirone is a drug marketed by Accord Hlthcare, Aiping Pharm Inc, Amneal Pharms Co, Aurobindo Pharma Ltd, Egis, Epic Pharma Llc, Heritage Pharma, Impax Labs Inc, Inventia Hlthcare, Ivax Sub Teva Pharms, Mylan, Nesher Pharms, Oxford Pharms, Rising, Rubicon Research, Strides Pharma, Teva, Unichem, and Zydus Pharms. and is included in twenty-one NDAs.
The generic ingredient in BUSPIRONE is buspirone hydrochloride. There are nineteen drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the buspirone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Buspirone
A generic version of BUSPIRONE was approved as buspirone hydrochloride by IMPAX LABS INC on March 28th, 2001.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BUSPIRONE?
- What are the global sales for BUSPIRONE?
- What is Average Wholesale Price for BUSPIRONE?
Summary for BUSPIRONE
| US Patents: | 0 |
| Applicants: | 19 |
| NDAs: | 21 |
| Drug Prices: | Drug price information for BUSPIRONE |
| Drug Sales Revenues: | Drug sales revenues for BUSPIRONE |
| DailyMed Link: | BUSPIRONE at DailyMed |
US Patents and Regulatory Information for BUSPIRONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Strides Pharma | BUSPIRONE HYDROCHLORIDE | buspirone hydrochloride | TABLET;ORAL | 202330-001 | Aug 25, 2014 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Inventia Hlthcare | BUSPIRONE HYDROCHLORIDE | buspirone hydrochloride | TABLET;ORAL | 209696-004 | May 3, 2018 | BX | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Heritage Pharma | BUSPIRONE HYDROCHLORIDE | buspirone hydrochloride | TABLET;ORAL | 204582-002 | Sep 18, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
